Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Dried Blood Spots: A New Tool for Tuberculosis Treatment OptimizationCurrent Pharmaceutical Design, 2011
- Pharmacokinetics of Rifampin and Clarithromycin in Patients Treated for Mycobacterium ulcerans InfectionAntimicrobial Agents and Chemotherapy, 2010
- Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trialThe Lancet, 2010
- Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and PitfallsTherapeutic Drug Monitoring, 2009
- Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable AbsorptionAntimicrobial Agents and Chemotherapy, 2008
- Low plasma concentrations of rifampicin in tuberculosis patients in IndonesiaThe International Journal of Tuberculosis and Lung Disease, 2002
- Clinical Pharmacokinetics of ClarithromycinClinical Pharmacokinetics, 1999
- Reduced Serum Levels Of Clarithromycin In Patients Treated With Multi-Drug Regimens Including Rifampin Or Rifabutin For Mycobacterium Avium-M. Intracellulare InfectionThe Journal of Infectious Diseases, 1995
- Clinical Pharmacokinetics of RifampicinClinical Pharmacokinetics, 1978